Please provide your email address to receive an email when new articles are posted on . Kidney Disease: Improving Global Outcomes is prioritizing its evidence-based guidelines, expanding the guideline ...
Please provide your email address to receive an email when new articles are posted on . Research investigating the mechanisms of anemia in patients with chronic kidney disease, as well as optimal ...
daily multivitamin does not reduce the risks of cvd in men Iron therapy and erythropoiesis-stimulating agents are not always effective for anemia in patients with CKD. Nutritional interventions may be ...
Updates on chronic kidney disease (CKD) diagnosis, use of sodium–glucose cotransporter-2 (SGLT-2) inhibitors as first-line therapy, and personalized treatment approaches for kidney and cardiovascular ...
In an update from the 2020 guideline, the Kidney Disease: Improving Global Outcomes (KDIGO) Work Group released the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney ...
COPENHAGEN, DENMARK, 31 March 2026 – BioPorto A/S (“BioPorto” or “Company”) (CPH: BIOPOR) today announced that the KDIGO 2026 Clinical Practice Guideline Draft for Acute Kidney Injury (AKI) and Acute ...
CAMBRIDGE, England--(BUSINESS WIRE)--As the European distributor of Invokana ® (canagliflozin) and Vokanamet ® (canagliflozin and metformin), Mundipharma welcomes the publication of the first KDIGO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results